Compare JKS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JKS | INNV |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2010 | 2021 |
| Metric | JKS | INNV |
|---|---|---|
| Price | $16.54 | $11.50 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $24.80 | $7.00 |
| AVG Volume (30 Days) | ★ 663.6K | 432.0K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $853,699,000.00 |
| Revenue This Year | N/A | $12.85 |
| Revenue Next Year | $14.60 | $8.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.76 |
| 52 Week Low | $14.95 | $3.13 |
| 52 Week High | $31.88 | $12.64 |
| Indicator | JKS | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 62.38 |
| Support Level | $15.14 | $7.33 |
| Resistance Level | $26.61 | $12.64 |
| Average True Range (ATR) | 0.81 | 0.76 |
| MACD | 0.25 | -0.10 |
| Stochastic Oscillator | 75.60 | 45.19 |
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.